A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 55, Issue 2, 2003, Pages 181-184

  Shahgaldian, Patrick ^a   Gualbert, Jérôme ^a   Aïssa, Kaïs ^a   Coleman, Anthony W ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

Atomic force microscopy; Calixarenes; Carbohydrates; Cryoprotectants; Solid lipid nanoparticles

Indexed keywords

CALIXARENE; CRYOPROTECTIVE AGENT; FRUCTOSE; GLUCOSE; MALTOSE; MANNOSE; SOLID LIPID NANOPARTICLE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CRYOPROTECTION; FREEZE DRYING; SPECTROSCOPY;

EID: 0037333422     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(02)00196-0     Document Type: Article

References (15)

1. Mehnert W., Mader K. Solid lipid nanoparticles. Production, characterization and applications. Adv. Drug Deliv. Rev. 47:2001;165-196.
2. Lian T., Ho R.J.Y. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90:2001;667-680.
3. Kreuter J. Nanoparticle-based drug delivery systems. J. Control. Release. 16:1991;169-176.
4. Jones M.C., Leroux J.C. Polymeric micelles - a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:1999;101-111.
5. Asfari Z., Bohmer V., Harrowfield J., Vicens J. Calixarene 2001. 2001;Kluwer, Dordrecht.
6. F. Perret, P. Shahgaldian, M. Mazzorana, A.W. Coleman, First Steps in the Study of the Cellular Toxicity of the Calixarenes, Book of Abstracts, XIth International Symposium on Supramolecular Chemistry, Fukuoka, Japan, 2000.
7. P. Shahgaldian, E. Da Silva, A.W. Coleman, A first approach to the study of calixarene solid lipid nanoparticle (SLN) toxicity, submitted for publication.
8. Gansey M.H.B.G., De Haan A.S., Bos E.S., Verboom W., Reinhoudt D.N. Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes. Model study to potential calix[4]arene-based Ac3+ chelators. Bioconjugate Chem. 10:1999;613-623.
9. E. Perrier, N. Terry, D. Rival, A.W. Coleman, Use of cyclodextrin derivatives for skin preparations, etc., their micelles or nanoparticles, and compositions containing the derivatives, French Patent FR 2000-6102, 2000.
10. Shahgaldian P., Cesario M., Goreloff P., Coleman A.W. Para-acyl calix[4]arene, amphiphilic self-assembly from the molecular to the mesoscopic level. J. Chem. Soc. Chem. Commun. 2002;326-327.
11. Shahgaldian P., Da Silva E., Coleman A.W., Rather B., Zaworotko M.J. Para-acyl-calixarene based solid lipid nanoparticles (SLNs): a detailed study of the preparation and stability parameters. Int. J. Pharm. 7348:2002;1-16.
12. Zimmerman E., Müller R.H., Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm. 196:2000;211-213.
13. Quitannar-Guerrero D., Ganem-Quintanar A., Alleman E., Fessi H., Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by emulsion-diffusion technique. J. Microencapsulation. 15:1998;107-119.
14. Miyajima K. Role of saccharides for the freeze-thawing and the freeze-drying of liposome. Adv. Drug Deliv. Rev. 24:1997;151-159.
15. Shahgaldian P., Coleman A.W., Kalchenko V.I. Synthesis and properties of novel calix[4]arene derivatives. Tetrahedron Lett. 42:2001;577-579.